eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Review: taking Suboxone and Adderall and DLPA and L-tyrosine and L-methylfolate together

Summary: drug interactions are reported among people who take Suboxone and Adderall and DLPA and L-tyrosine and L-methylfolate together.

This review analyzes the effectiveness and drug interactions between Suboxone and Adderall and DLPA and L-tyrosine and L-methylfolate. It is created by eHealthMe based on reports of 432 people who take the same drugs from FDA and social media, and is updated regularly.

 

You are not alone: join a support group for people who take Suboxone and Adderall and DLPA and L-tyrosine and L-methylfolate >>>

On Mar, 3, 2015: 432 people who take Suboxone, Adderall, DLPA, L-tyrosine, L-methylfolate are studied

Suboxone, Adderall, DLPA, L-tyrosine, L-methylfolate outcomes

Drug combinations in study:
- Suboxone (buprenorphine hydrochloride; naloxone hydrochloride)
- Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate)
- DLPA (phenylalanine)
- L-tyrosine (tyrosine)
- L-methylfolate (folic acid)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Suboxone is effective50.00%
(4 of 8 people)
83.33%
(20 of 24 people)
81.25%
(13 of 16 people)
85.00%
(17 of 20 people)
90.91%
(20 of 22 people)
66.67%
(4 of 6 people)
50.00%
(1 of 2 people)
100.00%
(3 of 3 people)
Adderall is effective21.43%
(3 of 14 people)
51.43%
(18 of 35 people)
55.56%
(10 of 18 people)
62.50%
(15 of 24 people)
72.00%
(18 of 25 people)
66.67%
(6 of 9 people)
75.00%
(3 of 4 people)
60.00%
(3 of 5 people)
DLPA is effectiven/a50.00%
(1 of 2 people)
n/an/an/an/an/an/a
L-tyrosine is effective0.00%
(0 of 1 people)
100.00%
(1 of 1 people)
100.00%
(1 of 1 people)
0.00%
(0 of 1 people)
0.00%
(0 of 1 people)
n/an/an/a
L-methylfolate is effectiven/a44.44%
(4 of 9 people)
50.00%
(2 of 4 people)
0.00%
(0 of 2 people)
66.67%
(2 of 3 people)
100.00%
(1 of 1 people)
100.00%
(1 of 1 people)
0.00%
(0 of 1 people)

Drug effectiveness by gender :

FemaleMale
Suboxone is effective86.79%
(46 of 53 people)
75.00%
(36 of 48 people)
Adderall is effective64.00%
(48 of 75 people)
48.21%
(27 of 56 people)
DLPA is effective0.00%
(0 of 1 people)
100.00%
(1 of 1 people)
L-tyrosine is effective33.33%
(1 of 3 people)
50.00%
(1 of 2 people)
L-methylfolate is effective58.33%
(7 of 12 people)
33.33%
(3 of 9 people)

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Suboxone is effectiven/an/a50.00%
(1 of 2 people)
50.59%
(43 of 85 people)
48.21%
(27 of 56 people)
41.18%
(7 of 17 people)
37.50%
(3 of 8 people)
50.00%
(1 of 2 people)
Adderall is effectiven/an/a20.00%
(1 of 5 people)
32.04%
(33 of 103 people)
31.94%
(23 of 72 people)
25.53%
(12 of 47 people)
40.00%
(6 of 15 people)
14.29%
(1 of 7 people)
DLPA is effectiven/an/an/a100.00%
(1 of 1 people)
0.00%
(0 of 5 people)
n/an/an/a
L-tyrosine is effectiven/an/an/a25.00%
(1 of 4 people)
n/a6.25%
(1 of 16 people)
n/a0.00%
(0 of 5 people)
L-methylfolate is effectiven/an/a33.33%
(1 of 3 people)
33.33%
(2 of 6 people)
33.33%
(1 of 3 people)
22.22%
(2 of 9 people)
33.33%
(1 of 3 people)
75.00%
(3 of 4 people)

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
DyspnoeaBack PainDrug Exposure During PregnancyDyspnoeaDepressionDrug Withdrawal SyndromeBell's PalsyOedema Peripheral
AnxietyNasopharyngitisDrug Withdrawal SyndromeDrug Withdrawal SyndromeConstipationInsomniaVitiligoAnxiety
DepressionSuicidal IdeationUmbilical Cord AbnormalityTherapeutic Response UnexpectedAnxietyLaboratory Test AbnormalEdema - Peripheral, Peripheral EdemaFatigue
ParanoiaConcussionDrug Withdrawal Syndrome NeonatalOedema PeripheralParanoiaHallucinations, MixedDepressionDepression
HyperhidrosisMuscle SpasmsRetained Placenta Or MembranesCardiac Failure CongestiveExhaustion, Fatigue, Lethargy, Tiredness, WearinessFolliculitisSluggishnessInsomnia
Euphoric MoodArthropathyPregnancy Induced HypertensionDepressionAneurysmAlopeciaHangover (excl Alcohol)Nausea
Therapeutic Response UnexpectedDepressionUterine InfectionEuphoric MoodFatigueLimb DiscomfortWeight GainBack Pain
Cardiac Failure CongestiveHigh Blood PressureApnoeaDehydrationHeadacheManiaPain
Oedema PeripheralMemory ImpairmentAsphyxiaAbortion SpontaneousPain In ExtremityStaphylococcal InfectionDrug Withdrawal Syndrome
Drug Withdrawal SyndromeAnxietyPolyhydramniosAccidental OverdoseDrug AbuseWeight IncreasedHeadache

Most common drug interactions by gender * :

FemaleMale
AnxietyFatigue
NauseaDrug Withdrawal Syndrome
PainOedema Peripheral
DepressionInsomnia
DiarrhoeaPsychotic Disorder
Back PainWeight Increased
HeadacheDepression
Oedema PeripheralRoad Traffic Accident
SomnolenceAggression
Vision BlurredAnxiety

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
Hypoglycaemia Neonataln/aExpressive Language DisorderAnxietyNauseaOedema PeripheralOedema PeripheralPain
Maternal Drugs Affecting FoetusAnorexiaNauseaUrinary Tract InfectionInsomniaNauseaOedema Peripheral
Diabetic FoetopathyEye RollingDepressionConvulsionDrug Withdrawal SyndromeHeadacheFatigue
Cardiomyopathy NeonatalJuvenile ArthritisHallucinationWeight DecreasedBack PainDepressionPain In Extremity
Breech PresentationWeight DecreasedNasopharyngitisDrug Withdrawal SyndromeFatigueFallEpistaxis
SomnolenceLoss Of ConsciousnessWeight IncreasedHeart Rate IncreasedSomnolenceAtrial Fibrillation
AngerBack PainDiarrhoeaManiaFoot FractureArthralgia
FatigueMaternal Exposure During PregnancyFatigueAnxietyDiarrhoeaDizziness
Diabetes MellitusHyperhidrosisVomitingLimb DiscomfortLacerationParaesthesia
Type 2 Diabetes MellitusHeadacheConstipationWeight IncreasedTransient Ischaemic AttackAnxiety

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Suboxone and Adderall and DLPA and L-tyrosine and L-methylfolate?

 

 

 

You are not alone! Join a related mobile support group on :
- support group for people who take Adderall
- support group for people who take DLPA
- support group for people who take L-methylfolate
- support group for people who take L-tyrosine
- support group for people who take Suboxone

Recent related drug studies (Check your drugs):

Related drug interaction studies:

Complete drug side effects:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.